Listen Score
LS 24
Global Rank
TOP 10%

ABOUT THIS PODCAST 🔗

Update frequency:
monthly
Average audio length:
40 minutes
Guest interviews
Has sponsors
English
United States
63 episodes
since Nov. 28, 2018
episodic

LATEST EPISODE 🔗

Finding cancer earlier and learning more about its biology creates new possibilities for care. It also creates more work for the pathologists who examine samples, interpret results, and help guide treatment decisions. In this episode of Talking Precision Medicine, Rafael Rosengarten welcomes back D…

SEARCH PAST EPISODES

Search past episodes of Talking Precision Medicine.

PREVIOUS EPISODES

AI can propose a molecule or suggest the next experiment. But someone still has to run the experiment, check the result, and decide what to do with it. In this episode of Talking Precision Medicine, Rafael Rosengarten talks with Stacie Calad-Thomson, Global BD Lead for BioPharma Labs & Manufact…
Are we measuring progress in AI-driven drug discovery the right way? Rafael Rosengarten explores this question with Andrii Buvailo, co-founder of BioPharmaTrend and one of the industry’s most perceptive analysts of AI in biotech and pharma.  They trace the evolution of AI-driven drug discovery, exa…
Artificial intelligence may be transforming drug discovery, but AI is only as powerful as the data it learns from. Behind many of today's scientific breakthroughs sits an invisible layer of expertly curated, harmonized knowledge that allows researchers to ask better questions and trust the answers.…
Mental health remains one of medicine's greatest unmet needs. In this episode, Jacob Hooker explains how Sensorium Therapeutics is searching for new psychiatric medicines by combining traditional plant knowledge with cutting-edge drug development. Jacob joins Rafael Rosengarten to discuss how centu…
In episode 58, Rafael sits down with James Zanewicz, CEO of Connect, to discuss the art and science of building innovation ecosystems. From Connect's origins as the world's first accelerator to the future of AI-powered healthcare, James shares lessons from a career spanning science, law, technology…
In this episode, Rafael Rosengarten sits down with Lisa Gurry, Chief Business Officer at GeneDx, to discuss the transformative role of genomic testing in rare disease diagnosis, therapeutic discovery, and precision medicine. Lisa shares GeneDx's mission to shorten the diagnostic odyssey for patient…
In this episode, Rafael Rosengarten sits down with Dr. Kamal Jethwani, VP of Digital Ventures at Moffitt Cancer Center, CEO of AccelerOnc Studio, and consulting CEO of Decimal Health. With over two decades in digital health, Kamal shares how Moffitt is transforming cutting-edge oncology expertise i…
Precision oncology promises more data, more insight, and better decisions, yet in practice it often brings more complexity. In a new episode Rafael Rosengarten is joined by Dr. Shakti Ramkissoon, VP of Oncology at Labcorp, to unpack the realities on the ground. From access gaps, reimbursement chall…
In this episode, Rafael Rosengarten speaks with Dr. Sean Khozin, CEO of the CEO Roundtable on Cancer. Sean shares how pre-competitive collaboration across industry, academia, and regulators is helping address some of the biggest challenges in oncology. The conversation explores the role of data sha…
Disclaimer: The podcast and artwork embedded on this page are from Genialis, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.